NEWS
Print Your Certificate
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
Ahmed Nabil
Menoufia University - Monufia / Egypt
Others
AD Scientific Index ID: 103088
جامعة المنوفية
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Ahmed Nabil's MOST POPULAR ARTICLES
1-)
Current concepts in the diagnosis and management of cytokine release syndromeDW Lee, R Gardner, DL Porter, CU Louis, N Ahmed, M Jensen, SA Grupp, ...Blood, The Journal of the American Society of Hematology 124 (2), 188-195, 201421712014
2-)
Human epidermal growth factor receptor 2 (HER2)–specific chimeric antigen receptor–modified T cells for the immunotherapy of HER2-positive sarcomaN Ahmed, VS Brawley, M Hegde, C Robertson, A Ghazi, C Gerken, E Liu, ...Journal of clinical oncology 33 (15), 1688, 20158102015
3-)
Her2-specific chimeric antigen receptor–modified virus-specific t cells for progressive glioblastoma: a phase 1 dose-escalation trialN Ahmed, V Brawley, M Hegde, K Bielamowicz, M Kalra, D Landi, ...JAMA oncology 3 (8), 1094-1101, 20174812017
4-)
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escapeM Hegde, M Mukherjee, Z Grada, A Pignata, D Landi, SA Navai, ...The Journal of clinical investigation 126 (8), 3036-3052, 20166692016
5-)
TanCAR: a novel bispecific chimeric antigen receptor for cancer immunotherapyZ Grada, M Hegde, T Byrd, DR Shaffer, A Ghazi, VS Brawley, A Corder, ...Molecular Therapy-Nucleic Acids 2, e105, 20135272013
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept